3D Bioprinting is a technique used for printing biomedical structures in laboratories using bioprinters & bioinks, including cells, biomaterials, bioactive molecules, etc. It is being implemented for tissues & organs for estimating the efficiency of clinical products like drugs, cosmetics, etc. Growing R&D activities, along with rising investments in bringing advanced medical technologies, are augmenting the demand for 3D bioprinting in order to create miniature tissue models for clinical testing procedures.
Market Insights & Analysis: Global 3D Bioprinting Market (2023-28)
The Global 3D Bioprinting Market is projected to grow at a CAGR of around 16% during the forecast period, i.e., 2023-28. The growth of the market is likely to be driven mainly by limited number of organ donors worldwide, which has instigated research organizations to develop complete organs inside laboratory setups, i.e., only possible through 3D bioprinting. Further, the mounting prevalence of kidney diseases, especially across North America & Asia-Pacific, is generating the need for kidney transplantation in case of a failure, thereby augmenting the demand for the development & fabrication of complex tissues & organs for replacement purposes.
3D bioprinting technology is also used for printing prosthetic limbs to replace missing limbs in individuals during treatment. It also leaves a lesser chance for graft rejection by host immunity while transplantation, as it utilizes the cells derived from the host’s blood. Hence, with the mounting need for research work & organ printing, the demand for 3D bioprinting components has increased significantly worldwide.
|Study Period||Historical Data: 2018-21|
|Base Year: 2022|
|Forecast Period: 2023-28|
|Regions Covered||North America: US, Canada, Mexico|
|Europe: Germany, The UK, France, Spain, Italy, Rest of Europe|
|Asia-Pacific: China, India, Japan, South Korea, Rest of Asia-Pacific|
|South America: Brazil, Argentina, Rest of South America|
|Middle East & Africa: UAE, Saudi Arabia, South Africa, Rest of MEA|
|Key Companies Profiled||Cellink, 3D Systems Corporation, Regemat 3D, Aspect Biosystems Ltd, Cyfuse Biomedical KK, Envision TEC GmbH, RegenHU SA, GeSIM GmbH, Inventia Life Science PTY LTD, Vivax Bio, Poietis, Advanced Solutions Life Sciences, LLC, Collplant Biotechnologies Ltd., Regenovo Biotechnology Co. Ltd., Others|
|Unit Denominations||USD Million/Billion|
Additionally, the heightened adoption of regenerative medicines by healthcare organizations, especially for wound care, & cell therapy has enhanced the adoption of 3D bioprinting. The use across regenerative medicines is increasing significantly, as it utilizes them for creating precise tissue geometry to repair, replace & regenerate damaged tissues. Further, as regenerative medicines are used to treat a large range of diseases like Parkinson’s disease, renal disease, cardiovascular diseases, cancers, etc., therefore, rising cases of such diseases would also increase the demand for regenerative medicines. Hence, this would substantially uplift the demand for 3D bioprinting components worldwide for providing specialized regenerative medicines.
Moreover, the toxicological screening of chemical compounds like drugs, household & industrial chemicals, and cosmetic ingredients, over human tissues, further creates a need for 3D bioprinting. Since the technology is used to create constructs that would mimic the physiology and functions of human tissues, therefore, it is actively used in toxicology testing services to identify the adverse effects of chemicals on living organisms and their environment.
Also, the rising focus of pharmaceutical companies and research organizations, to perform carcinogenic toxicity tests for various drugs and cosmetics has been significantly propelling the need for animal models. Along with this, the test to detect skin corrosion, skin absorption, skin sensitization, & skin irritation, for cosmetic products, also propels the demand for models mimicking human tissue structures. Subsequently, the demand would increase in the forecasted years as it would be required to create tissue constructs for real-time monitoring and screening of the products.
Global 3D Bioprinting Market Key Trend:
Surge in Demand for 3D models for Cancer Research - With the increasing rate of new cancer cases worldwide, the use of 3D bioprinting has also increased significantly, as it allows the creation of a cancer microenvironment inside laboratory setups. The recapitulation of the cancer microenvironment makes it convenient for the researcher to study cancer pathogenesis and metastasis accurately. Further, in 2018, according to the National Cancer Institute (NCI), the number of cancer cases was around 18.1 million, which is expected to rise to 29.5 million by the end of 2040.
Therefore, with the rising cases of cancer worldwide, the need for 3D bioprinting would also increase in the forecasted years, as 3D models in cancer research allow the efficient study of cell-to-cell interactions. Moreover, 3D cancer models are also actively used in cancer research to study the progression of cancer along with testing of the efficiency of various cancer treatment methods against carcinogens.
Global 3D Bioprinting Market (2023-28): Segmentation Analysis
The Global 3D Bioprinting Market study of MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment & includes predictions for the period 2023–2028 at the global, regional, and national levels. Based on the Component, and Technology the market has been further classified as:
Based on Component:
Of both, bioprinters held a major share of the overall market globally, owing to their greater contribution to revenue generation, because of high cost. Further, with the rising technological advancements and rising demand for organ transplantation, the need for 3D bioprinters increased significantly across the globe. Moreover, the increasing technological advancements in 3D printers for use in several applications, such as inkjet bioprinters, extrusion-based bioprinters, laser-based bioprinters, etc., further increase their demand among various end-user groups.
Based on Technology:
Here, inkjet-based bioprinting witnessed substantial growth during the historical years, owing to its highest demand coming from the healthcare industry. The inkjet-based bioprinting technology is mostly used for the regeneration of skin and cartilage tissues, which allows their direct deposition on injured tissues. In addition, they are also utilized in the deposition of primary and stem cells, which enhances their applications in stem cell biology research.
Consequently, greater durability and enhanced application in biochemical regeneration also supported the growth of inkjet-based 3D bioprinting across the globe. Besides, Magnetic Levitation Bioprinting is projected to grow at a considerable rate, owing to its high cost-effectiveness and enhanced features like high speed and accuracy. Further, the major demand for this technique comes from the applications like tissue repairing, toxicity testing, and vascular muscle printing.
Global 3D Bioprinting Market Regional Projection
Geographically, the Global 3D Bioprinting Market expands across:
Across the geographies, North America accounted for the major share in the Global market during 2018-2022. The major factor responsible for the market growth is the significant government and private investments in the research and development of 3D bioprinting technologies. Further, the higher adoption of newer technologies and the presence of major market players across the region also contributed to the major share of the region in the Global market.
Besides, Asia Pacific is anticipated to witness significant growth in the forthcoming years, owing to the presence of a strong consumer base, that would generate the demand for 3D bioprinting in medical services. Further, the increasing development in innovation, and adoption of the technology by several pharmaceuticals, cosmetology, and research organizations in the region, further support the growth of the 3D bioprinting market across the region during 2023-2028.
Global 3D Bioprinting Industry Recent Developments
Global 3D Bioprinting Market Key Driver:
Increasing Demand in Pharmaceutical & Cosmetology Industries - The increasing demand for 3D bioprinting by pharmaceuticals and cosmetic companies for drug or other product testing has been uplifting the growth of the market. Also, traditional drug testing methods take more than 10 years to take to the market and also involves high cost for testing over animal models. However, the models created with 3D bioprinting allow pharmaceutical companies to safely and economically carry out clinical drug testing procedures.
As a result, the companies are actively utilizing 3D models for drug testing through the incorporation of workflows with lower costs, which allows for the screening of a large number of drugs with smaller amounts of compounds. In addition, the 3D bio-printed models also allow for tackling the ethical issues that are linked to the use of animal models during drug testing. Hence, their usage is further increased to replace, reduce and refine the use of animals in medical research.
Global 3D Bioprinting Market Possible Restraint:
Dearth of Skilled Professionals has been Restraining the Market Growth??????? - The continuous technological advancements in 3D bioprinting require skilled professionals, as the critical environment required for the procedure needs continuous monitoring by experts. Additionally, 3D bioprinting is also an emerging field in the healthcare industry, which requires trained professionals to operate the 3D bioprinter efficiently. Apart from this, any inconsistency in process monitoring, such as the difference between batches, machines, and materials, would severely affect the end product of the procedure.
Additionally, the procedure also requires professionals who have an understanding of spacial object designing, as it is more complicated to create geometrical structures in 3D. Therefore, with the shortage of skilled professionals, the market has been experiencing a significant impact on growth, as skilled professionals are highly critical in 3D bioprinting to handle operations and troubleshooting activities.
Global 3D Bioprinting Market Growth Opportunity:
Use of 3D Bioprinting for Personalized and Precision Medicine Development??????? - The use of 3D bioprinters in the biofabrication of personalized medicines like drug delivery devices, biomedical implants, and biosensors, is anticipated to create a great opportunity for the growth of the Global 3D Bioprinting market. There is an intensifying demand for personalized and precision medicines that are incorporated with living cells or biomaterials, owing to their features like biocompatible and non-cytotoxic. Therefore, the use of 3D bioprinters is enhancing significantly, as they allow personalized drugs to safely interact with a patient’s biological system, and they also help in the reduction of side effects linked with these medicines. For instance,
Hence, the use of 3D bioprinters for the biofabrication of personalized medicines like cardiac patches, cancer patches, wound-healing patches, etc., would be a great opportunity for the growth of the market.
Gain a Competitive Edge with Our Global 3D Bioprinting Market Report
Frequently Asked Questions
A. The 3D Bioprinting Market is set to record around 16% CAGR during 2023-28.
A. Bioprinter is the leading component in the 3D Bioprinting Market during 2023-28.
A. The ever-increasing demand for 3D bioprinting across the pharmaceutical & cosmetology industries is the major factor projected to drive the market through 2028.
A. The key companies operating in the 3D Bioprinting Market include Cellink, 3D Systems Corporation, Regemat 3D, Aspect Biosystems Ltd, Cyfuse Biomedical KK, Envision TEC GmbH, RegenHU SA, GeSIM GmbH, Inventia Life Science PTY LTD, Vivax Bio, Poietis, Advanced Solutions Life Sciences, LLC, Collplant Biotechnologies Ltd., and Regenovo Biotechnology Co. Ltd.
A. The surge in demand for 3D models for cancer research is a key trend boding well for the 3D Bioprinting Market expansion.
A. The dearth of skilled professionals shall restrain the growth of the 3D Bioprinting Market during 2023-28.
Global 3D Bioprinting Market Research Report (2023-2028) - Table of Contents